Tech Company Financing Transactions
Medeor Therapeutics Funding Round
Medeor Therapeutics, operating out of San Mateo, secured $57 million from RA Capital, 6 Dimensions Capital and Sofinnova Ventures.
Transaction Overview
Company Name
Announced On
11/28/2017
Transaction Type
Venture Equity
Amount
$57,000,000
Round
Series B
Investors
RA Capital (Lead Investor) (Peter Kolchinsky)
Sofinnova Ventures (Anand Mehra)
Proceeds Purpose
This financing will support the Phase 3 clinical trial of MDR-101 in living donor HLA-matched kidney transplant patients, being conducted under a Special Protocol Agreement with the FDA, as well as a Phase 2b trial of MDR-102 in living donor HLA-mismatched kidney transplant patients.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
1875 South Grant St. 130
San Mateo, CA 94402
USA
San Mateo, CA 94402
USA
Phone
Website
Email Address
Overview
MEDEOR THERAPEUTICS is a private, late clinical stage, biotechnology company dedicated to the discovery, development, and commercialization of transformative and personalized cellular immunotherapies.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Steven Deitcher
Chief Financial Officer
Matthew Plunkett
Chief Medical Officer
Scott Batty
Vice President
Iqbal Husain
VP - Operations
Michael Zdanowski
VP - Regulatory Affairs
Darin Weber
Browse more venture capital transactions:
Prev: 11/28/2017: Lyft venture capital transaction
Next: 11/28/2017: Niantic venture capital transaction
Share this article
About Database of VC Transactions
We record funding rounds that are announced publicly. VC investment data records reported here are sourced from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs